Medchemexpress/SB 216763/HY-12012/10mM*1mL in DMSO_蚂蚁淘，【正品极速】生物医学科研用品轻松购|ebiomall 蚂蚁淘商城

商品信息

联系客服

Medchemexpress/SB 216763/HY-12012/10mM*1mL in DMSO

郑重提醒：

无质量问题不接受退换货，下单前请仔细核对信息。

下单后请及时联系客服核对商品价格，订单生效后再付款。

Medchemexpress/SB 216763/HY-12012/10mM*1mL in DMSO

品牌 /

MedChemExp

货号 /

HY-12012-5mg

官网地址

美元价：

登录查看

(友情提示：该价格仅为参考，欢迎联系客服询价！)

数量：

免费咨询热线

4000-520-616

商品介绍售后保障相关文章商品咨询

联系客服

SB216763ispotentandselectiveglycogensynthasekinase-3(GSK-3)inhibitor,withIC₅₀valueof34.3nMforGSK-3αandGSK-3β,respectively.

CustomerValidation

•ToxicolApplPharmacol.2016Dec15;313:195-203.
•HarvardMedicalSchoolLINCSLIBRARY

Description	SB216763ispotentandselectiveglycogensynthasekinase-3(GSK-3)inhibitor,withIC₅₀valueof34.3nMforGSK-3αandGSK-3β,respectively.
IC₅₀&Target	IC50:34.3nM(GSK-3α),34.3nM(GSK-3β)^[5]
InVitro	SB-216763(10-20µM)inducesβ-cateninmediated-transcriptioninadose-dependentmannerinHEK293cells.SB-216763(10,15and20µM)canmaintainmESCswithapluripotent-likemorphologyinlong-termculture.SB-216763(10µM)canmaintainJ1mESCsinapluripotentstateformorethanamonth^[2].SB-216763inhibitsGSK-3withIC₅₀of34nM^[3].SB-216763isequallyeffectiveatinhibitinghumanGSK-3αandGSK-3β^[5].
InVivo	SB216763(20mg/kg,i.v.)significantlyimprovesthesurvivalofBLM-treatedmice.MicerandomizedtoreceiveBLMplusSB216763showsanoteworthyreduction,comparedwithBLM-treatedmice.SB216763(20mg/kg,i.v.)reducesthemagnitudeofBLM-inducedalveolitis^[1].SB216763(0.2mg/kg,i.v.)witheither17β-E₁₀₀orGeni₁₀₀reversestheceilingeffectbecausetheseagentssignificantlyreduceinfarctsizewhentherabbits"heartsaresubmittedto30-minCAO^[4].
References	[1].Gurrieri,etal.3-(2,4-dichlorophenyl)-4-(1-methyl-1H-indol-3-yl)-1H-pyrrole-2,5-dione(SB216763),aglycogensynthasekinase-3inhibitor,displaystherapeuticpropertiesinamousemodelofpulmonaryinflammationandfibrosis.J.Pharmacol.Exp.Ther.2010 [2].KirbyLA,etal.Glycogensynthasekinase3(GSK3)inhibitor,SB-216763,promotespluripotencyinmouseembryonicstemcells.PLoSOne.2012;7(6):e39329.Epub2012Jun26. [3].WangM,etal.Thefirstsynthesisof[(11)C]SB-216763,anewpotentialPETagentforimagingofglycogensynthasekinase-3(GSK-3).BioorgMedChemLett.2011Jan1;21(1):245-9.Epub2010Nov11. [4].TheceilingeffectofpharmacologicalpostconditioningwiththephytoestrogengeNISTeinisreversedbytheGSK3betainhibitorSB216763[3-(2,4-dichlorophenyl)-4(1-methyl-1H-indol-3-yl)-1H-pyrrole-2,5-dione]throughmitochondrialATP-dependentpotassiumchannelopening. [5].CoghlanMP,etal.Selectivesmallmoleculeinhibitorsofglycogensynthasekinase-3modulateglycogenmetabolismandgenetranscription.ChemBiol.2000Oct;7(10):793-803. [6].WangW,etal.Inhibitionofglycogensynthasekinase3betaamelioratestriptolide-inducedacutecardiacinjurybydesensitizingmitochondrialpermeABIlitytransition.ToxicolApplPharmacol.2016Dec15;313:195-203.

PreparingStockSolutions

ConcentrationVolumeMass	1mg	5mg	10mg

1mM	2.6938mL	13.4691mL	26.9382mL
5mM	0.5388mL	2.6938mL	5.3876mL
10mM	0.2694mL	1.3469mL	2.6938mL

Pleaserefertothesolubilityinformationtoselecttheappropriatesolvent.

CellAssay
^[2]

SB-216763isdissolvedin0.1%DMSO.

MESCsmaintainedwithLIFor10µMSB-216763formorethanamonthareresUSPendedat40,000cells/mLinLIF-freemESCmedium.EBsarepreparedbyahangingdropprocedure.Briefly,20µLdropscontainingmESCsarePipettedontheinsideofa10-cmPetridishlid.ThelidsareplacedontoPetridishescontaining10mLofHBSSandtheEBsareallowedtoformandgrowfor4daysintheincubator.After4days,15-20EBsaretransferredtoawellcontainingLIF-freemESCmediumina24-wellplate.Themediumisexchangedeverytwodaysandautonomouslybeatingcellaggregatesareobservedandcounted.MCEhasnotindependentlyconfirmedtheaccuracyofthesemethods.Theyareforreferenceonly.

AnimalAdministration
^[1]

SB216763isdissolvedinvehicle(25%dimethylsulfoxide,25%polyethyleneglycol,and50%saline).

Miceareallocatedtofourgroups(n=12/group)asfollows:1)intratrachealsaline+vehicle(25%dimethylsulfoxide,25%polyethyleneglycol,and50%saline),2)intratrachealsaline+SB216763(20mg/kg)dissolvedinvehicle,3)intratrachealBLM(3U/kg)+vehicle,and4)intratrachealBLM+SB216763(20mg/kg)invehicle.Anothersetofexperimentstoassesscytokineexpressionbyreversetranscription-PCRisconductedinthemice(n=12/group)toreceive1)intratrachealsaline+vehicle,2)intratrachealBLM,and3)intratrachealBLM+SB216763.Toinducepulmonaryfibrosis,BLMisintratracheallyadministeredinmice(n=15/group)onday0.BLMandsaline-treatedmiceareadministeredwithSB216763dissolvedinvehicleorvehiclealoneintravenouslyatday0andthenintraperitoneallytwiceaweekuntilday28.MicearesacrificedbyCO₂ inhalationondays2,7,and28.IntheterminaldeoxynucleotidyltransferasedUTPnick-endlabeling(TUNEL)experiments,thecohortsofmiceareasfollows:saline-treated(n=6),BLM-treated(n=6),andBLM+SB216763-treated(n=6).MCEhasnotindependentlyconfirmedtheaccuracyofthesemethods.Theyareforreferenceonly.

References

[1].Gurrieri,etal.3-(2,4-dichlorophenyl)-4-(1-methyl-1H-indol-3-yl)-1H-pyrrole-2,5-dione(SB216763),aglycogensynthasekinase-3inhibitor,displaystherapeuticpropertiesinamousemodelofpulmonaryinflammationandfibrosis.J.Pharmacol.Exp.Ther.2010
[2].KirbyLA,etal.Glycogensynthasekinase3(GSK3)inhibitor,SB-216763,promotespluripotencyinmouseembryonicstemcells.PLoSOne.2012;7(6):e39329.Epub2012Jun26.
[3].WangM,etal.Thefirstsynthesisof[(11)C]SB-216763,anewpotentialPETagentforimagingofglycogensynthasekinase-3(GSK-3).BioorgMedChemLett.2011Jan1;21(1):245-9.Epub2010Nov11.
[4].TheceilingeffectofpharmacologicalpostconditioningwiththephytoestrogengenisteinisreversedbytheGSK3betainhibitorSB216763[3-(2,4-dichlorophenyl)-4(1-methyl-1H-indol-3-yl)-1H-pyrrole-2,5-dione]throughmitochondrialATP-dependentpotassiumchannelopening.
[5].CoghlanMP,etal.Selectivesmallmoleculeinhibitorsofglycogensynthasekinase-3modulateglycogenmetabolismandgenetranscription.ChemBiol.2000Oct;7(10):793-803.
[6].WangW,etal.Inhibitionofglycogensynthasekinase3betaamelioratestriptolide-inducedacutecardiacinjurybydesensitizingmitochondrialpermeabilitytransition.ToxicolApplPharmacol.2016Dec15;313:195-203.

MolecularWeight

371.22

Formula

C₁₉H₁₂Cl₂N₂O₂

CASNo.

280744-09-4

Storage

Powder	-20°C	3years
	4°C	2years
Insolvent	-80°C	6months
	-20°C	1month

Shipping

RoomtemperatureincontinentalUS;mayvaryelsewhere

Solvent&Solubility

10mMinDMSO

SB216763isdissolvedinDMSOtomakestocksolutionsandthensuspendedinnormalsaline^[6].

*"<1 mg/ml"="" means="" slightly="" soluble="" or="" insoluble.="" "≥"="" means="" soluble,="" but="" saturation="">

References

[1].Gurrieri,etal.3-(2,4-dichlorophenyl)-4-(1-methyl-1H-indol-3-yl)-1H-pyrrole-2,5-dione(SB216763),aglycogensynthasekinase-3inhibitor,displaystherapeuticpropertiesinamousemodelofpulmonaryinflammationandfibrosis.J.Pharmacol.Exp.Ther.2010
[2].KirbyLA,etal.Glycogensynthasekinase3(GSK3)inhibitor,SB-216763,promotespluripotencyinmouseembryonicstemcells.PLoSOne.2012;7(6):e39329.Epub2012Jun26.
[3].WangM,etal.Thefirstsynthesisof[(11)C]SB-216763,anewpotentialPETagentforimagingofglycogensynthasekinase-3(GSK-3).BioorgMedChemLett.2011Jan1;21(1):245-9.Epub2010Nov11.
[4].TheceilingeffectofpharmacologicalpostconditioningwiththephytoestrogengenisteinisreversedbytheGSK3betainhibitorSB216763[3-(2,4-dichlorophenyl)-4(1-methyl-1H-indol-3-yl)-1H-pyrrole-2,5-dione]throughmitochondrialATP-dependentpotassiumchannelopening.
[5].CoghlanMP,etal.Selectivesmallmoleculeinhibitorsofglycogensynthasekinase-3modulateglycogenmetabolismandgenetranscription.ChemBiol.2000Oct;7(10):793-803.
[6].WangW,etal.Inhibitionofglycogensynthasekinase3betaamelioratestriptolide-inducedacutecardiacinjurybydesensitizingmitochondrialpermeabilitytransition.ToxicolApplPharmacol.2016Dec15;313:195-203.

Purity:97.00%

SelectBatch: